Filing Details
- Accession Number:
- 0001104659-15-044672
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-06-10 18:01:48
- Reporting Period:
- 2015-06-08
- Filing Date:
- 2015-06-10
- Accepted Time:
- 2015-06-10 18:01:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1070081 | Ptc Therapeutics Inc. | PTCT | Pharmaceutical Preparations (2834) | 043416587 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1578852 | Elliott Mark Boulding | C/O Ptc Therapeutics, Inc. 100 Corporate Court South Plainfield NJ 07080 | Exec Vp And Clo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-06-08 | 12,083 | $10.85 | 23,176 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-06-08 | 50,000 | $10.85 | 73,176 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-06-08 | 10,776 | $53.87 | 62,400 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-06-08 | 18,324 | $54.70 | 44,076 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-06-08 | 24,609 | $55.62 | 19,467 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-06-08 | 3,140 | $56.42 | 16,327 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2015-06-08 | 12,083 | $0.00 | 12,083 | $10.85 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2015-06-08 | 50,000 | $0.00 | 50,000 | $10.85 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 7,917 | 2023-05-15 | No | 4 | M | Direct | |
| 50,000 | 2023-05-15 | No | 4 | M | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | $27.05 | 2024-01-27 | 80,000 | 80,000 | Direct | |
| Common Stock | Stock Option (Right to Buy) | $51.00 | 2025-01-01 | 85,600 | 85,600 | Direct | |
| Common Stock | Stock Option (Right to Buy) | $218.40 | 2022-01-10 | 191 | 191 | Direct | |
| Common Stock | Stock Option (Right to Buy) | $490.80 | 2021-04-27 | 233 | 233 | Direct | |
| Common Stock | Stock Option (Right to Buy) | $1,149.60 | 2020-02-02 | 200 | 200 | Direct | |
| Common Stock | Stock Option (Right to Buy) | $451.20 | 2019-05-15 | 233 | 233 | Direct | |
| Common Stock | Stock Option (Right to Buy) | $735.60 | 2018-04-01 | 195 | 195 | Direct | |
| Common Stock | Stock Option (Right to Buy) | $735.60 | 2018-01-25 | 166 | 166 | Direct | |
| Common Stock | Stock Option (Right to Buy) | $626.40 | 2017-04-18 | 216 | 216 | Direct | |
| Common Stock | Stock Option (Right to Buy) | $392.40 | 2016-03-01 | 101 | 101 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2024-01-27 | 80,000 | 80,000 | Direct |
| 2025-01-01 | 85,600 | 85,600 | Direct |
| 2022-01-10 | 191 | 191 | Direct |
| 2021-04-27 | 233 | 233 | Direct |
| 2020-02-02 | 200 | 200 | Direct |
| 2019-05-15 | 233 | 233 | Direct |
| 2018-04-01 | 195 | 195 | Direct |
| 2018-01-25 | 166 | 166 | Direct |
| 2017-04-18 | 216 | 216 | Direct |
| 2016-03-01 | 101 | 101 | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person for the primary purposes of diversification.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $53.26 to $54.25 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $54.26 to $55.19 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $55.26 to $56.21 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $56.29 to $56.63 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on December 31, 2013 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on January 31, 2014.
- This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on May 15, 2014 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on June 15, 2014.
- This option was granted on January 28, 2014 and vests over four years, with 25% of the shares underlying the option vested on January 1, 2015 and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2015.
- This option was granted on January 2, 2015 and vests over four years, with 25% of the shares underlying the option vesting on January 1, 2016 and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2016.
- This option was granted on January 10, 2012 and vests over four years, with 25% of the shares underlying the option vested on January 1, 2013 and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2013.
- Currently exercisable.
Billionaire Hedge Funds
